SCHEDULE: Malone Wealth Ventures Discloses 21.8% Stake in Quantum Biopharma Ltd.
Beneficial Ownership Report
Malone Wealth Ventures LLC has filed an amended Schedule 13G, reporting a beneficial ownership of 21.8% of Quantum Biopharma Ltd.'s common stock.
Summary
- Malone Wealth Ventures LLC, an investment adviser based in the United States, reported beneficial ownership of 829,730 shares of Quantum Biopharma Ltd.'s Common Stock.
- This ownership represents 21.8% of the total class of securities.
- Malone Wealth Ventures LLC holds sole voting power over 105,151 shares and sole dispositive power over all 829,730 shares.
- The filing, Amendment No. 6, indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Quantum Biopharma Ltd.
- Clients of Malone Wealth Ventures LLC have the right to receive dividends or proceeds from the sale of these securities, with no individual client holding more than five percent of the class.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate a positive or negative sentiment regarding the company's performance or outlook.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
NA
Management Comments
- The securities referred to were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake in the company, which could influence investor perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 07/18/2025 | Date of event which requires filing of this statement and signature date of the filing. |
Keywords
Quantum Biopharma Ltd., Malone Wealth Ventures LLC, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Shareholder Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.